Minerva Neurosciences, Inc. (NERV)

Price & Market Data

Price: $5.60

Daily Change: -$0.03 / 0.54%

Daily Range: $5.58 - $5.74

Market Cap: $260,896,768

Daily Volume: 79,974

Performance Metrics

1 Week: -10.40%

1 Month: -1.75%

3 Months: -11.25%

6 Months: 50.94%

1 Year: 243.3%

YTD: 39.30%

About Minerva Neurosciences, Inc. (NERV)

Data on Minerva Neurosciences, Inc. (NERV). Price: 5.60, daily change: -$0.03 / 0.54%. Market cap: 260,896,768. Performance YTD and 1-year.

Company Details

Employees: 7

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Selected stocks

XFLH Capital Corporation (XFLH-UN)

Algonquin Power & Utilities Corp. (AQN)

Healthcare Services Group, Inc. (HCSG)

Can-Fite Biopharma Ltd (CANF)

Gentex Corporation (GNTX)